Ab&B fortifies for battle over China’s vaccine market
With proceeds from a Hong Kong IPO, the loss-making biotech is bidding for a piece of China’s fiercely competitive market for flu and human rabies vaccines Key Takeaways: The company’s…
In EV battery race, Sunwoda boasts edge with profitable consumer business
The company has filed for a Hong Kong IPO, seeking new funds to support development of its EV battery business Key Takeaways: Sunwoda is seeking funds from a Hong Kong…
IPO applicant Lemo faces cash squeeze and credibility questions
The operator of massage chairs in public spaces is making a renewed pitch to investors amid a lingering controversy about its business data Key Takeaways: The firm deploys massage chairs…
Its Hong Kong listing advancing, will investors drink up Bama Tea shares?
After three failed listing attempts, the tea leaf seller has received a key regulatory green light for its planned IPO from China’s securities watchdog Key Takeaways: Bama Teach has been…
Yimutian cultivates investors for China’s new agricultural revolution
The agricultural B2B marketplace operator has filed for a Nasdaq IPO, reporting its revenue declined last year as it engages in aggressive cost-cutting Key Takeaways: Yimutian has filed for a…
Zhida seeks to recharge its finances with another IPO bid
The maker of charging techology for electric vehicles risks running out of juice to manage its cash flow and fund its international expansion plans Key Takeaways: The company managed to…
PomDoc offers up well-conceived but overvalued digital healthcare IPO
The online health services provider aims to raise up to $30 million through a Nasdaq listing, even as its liabilities far outweigh its assets Key Takeaways: PomDoc aims to raise…